Gene · 5819
NECTIN2: nectin cell adhesion molecule 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NECTIN2: nectin cell adhesion molecule 2. Genes, record 5819. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5819
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92692 | Nectin-2 | 538 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents155
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4831196 A2 | 2026-10-28 | 21 | Q92692 | Espacenet |
| US 12624087 B2 | 2026-05-12 | 21 | Q92692 | Espacenet |
| US 12612446 B2 | 2026-04-28 | 462 | Q92692 | Espacenet |
| JP 2026049003 A | 2026-03-17 | 8 | Q92692 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 58296 | Q92692 | Espacenet |
| JP 2026500896 A | 2026-01-09 | 9 | Q92692 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1386 | Q92692 | Espacenet |
| WO 2025235604 A1 | 2025-11-13 | 9 | Q92692 | Espacenet |
| WO 2025235605 A1 | 2025-11-13 | 9 | Q92692 | Espacenet |
| JP 2025166053 A | 2025-11-05 | 21 | Q92692 | Espacenet |
1 to 10 of 155
See all 155 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,062
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NECTIN2 papers | Newest fiscal year |
|---|---|---|---|
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 23 | 2025 |
| P01AI039671 | Costimulatory Mechanisms of Autoimmunity | 12 | 2025 |
| P30EY001792 | P30 Core Grant for Vision Research | 12 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| P30AG066468 | Alzheimer Disease Research Center | 9 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 8 | 2025 |
| P01CA111412 | NK cells, their receptors and cancer therapy | 7 | 2025 |
| P30AG062429 | UCSD Shiley-Marcos Alzheimer's Disease Research Center P30 | 7 | 2025 |
| P30AG066444 | Alzheimer's Disease Research Center | 7 | 2025 |
| P30AG072976 | Indiana Alzheimer's Disease Research Center | 7 | 2025 |
1 to 10 of 2,062Source NIH's project files
See all 2,062 nih grantsPapers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: NECTIN2 depletion impairs migration and invasion in MDA-MB-231 breast cancer cells through LIMK1-associated cytoskeletal remodeling. | PLoS One | 2026 | 42789498 | PubTator, text mining | PubMed |
| Genetic Prioritization of Plasma Proteins Across Dementia Subtypes: A Proteome-Wide Mendelian Randomization and Bayesian Colocalization Analysis. | Cell Mol Neurobiol | 2026 | 42782355 | PubTator, text mining | PubMed |
| Proteome-wide genetic study identified therapeutic targets for early-onset and late-onset Alzheimer's disease. | Int J Surg | 2026 | 42682321 | PubTator, text mining | PubMed |
| NECTIN2 depletion impairs migration and invasion in MDA-MB-231 breast cancer cells through LIMK1-associated cytoskeletal remodeling. | PLoS One | 2026 | 42664293 | PubTator, text mining | PubMed |
| Linoleic acid metabolic reprogramming is linked to immunometabolic remodeling and post-transplant recurrence risk in hepatocellular carcinoma. | Front Immunol | 2026 | 42643672 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals IRF1-Driven Epithelial States and Glycosaminoglycan-Glycolysis Coupling in Cisplatin-Resistant HGSOC. | Cancer Inform | 2026 | 42605287 | PubTator, text mining | PubMed |
| Endothelial Cell Proteins as Biomarkers in Susac Syndrome. | Ann Clin Transl Neurol | 2026 | 42593056 | PubTator, text mining | PubMed |
| Metabolism Pathway Blood Proteomic Differences in Lewy Body Dementia Compared to Alzheimer's Disease. | Int J Mol Sci | 2026 | 42589529 | PubTator, text mining | PubMed |
| Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy. | Hepatol Commun | 2026 | 42566272 | PubTator, text mining | PubMed |
| Single-Cell Transcriptional States of Human Leukocyte Antigen DR Positive CD4 Positive T Cells Linked to Genetic Susceptibility of Gastric Cancer. | Immunol Invest | 2026 | 42560142 | PubTator, text mining | PubMed |
1 to 10 of 2,573
See all 2,573 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5819
GET https://conductscience.org/api/genes/v1/5819/patents?page=2